MedPharm is a CDMO that specializes in topical and transepithelial delivery methods for pharmaceutical products. With a focus on assisting pharma companies navigate the complex process of bringing new products to market, MedPharm aims to provide more opportunities for success at every stage of development. Established in 1999 and headquartered in the United States, the company received its most recent Venture Round investment on 26 March 2018 from Ampersand Capital Partners.
By leveraging their expertise in research, trial material manufacturing, and commercial production, MedPharm positions itself as the global gold standard in the field of topical and transepithelial CDMO services. Their commitment to understanding and anticipating the needs of partners, in addition to adapting to market changes, regulatory environments, and scientific advancements, sets them apart in the Biotechnology, Manufacturing, Pharmaceutical, and Platforms industries. Their slogan, "Breaking through boundaries," encapsulates their approach to providing innovative solutions for their clients' drug pipeline needs.